Hypermethylation of tumor necrosis factor decoy receptor gene in non-small cell lung cancer

Yuanlin Qi1, Lin Qi1, Minglian Qiu2

  • 1School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian 350122, P.R. China.

Oncology Letters
|June 23, 2020
PubMed

Insights

Hypermethylation of the TNFRSF10C gene is associated with non-small cell lung cancer (NSCLC). This study found higher TNFRSF10C methylation in NSCLC tumors, particularly in male and non-smoking patients, and linked it to reduced gene expression.

Area of Science:

  • Molecular Oncology
  • Epigenetics
  • Cancer Genomics

Background:

  • Aberrant methylation of TNFRSF10C and TNFRSF10D genes is implicated in various cancers.
  • Previous research has not explored the methylation status of these genes in non-small cell lung cancer (NSCLC).
  • Understanding gene methylation patterns is crucial for identifying novel biomarkers and therapeutic targets in NSCLC.

Purpose of the Study:

  • To investigate the association between TNFRSF10C and TNFRSF10D gene methylation and the occurrence of NSCLC.
  • To explore potential correlations between methylation levels, patient demographics, and gene expression.
  • To elucidate the functional impact of TNFRSF10C methylation on gene transcription.

Main Methods:

  • Quantitative methylation-specific PCR (QMSP) was employed to analyze methylation levels in 44 pairs of NSCLC tumor and adjacent non-tumor tissues.
  • Analysis of The Cancer Genome Atlas (TCGA) lung cancer data and cBioPortal was performed to correlate methylation with mRNA expression.
  • In vitro experiments included demethylation of NSCLC cell lines (A549, NCI-H1299) and a dual luciferase reporter gene assay to assess transcriptional activity.

Main Results:

  • Significantly higher TNFRSF10C methylation levels were observed in NSCLC tumor tissues compared to non-tumor tissues (P=0.013).
  • Elevated TNFRSF10C methylation was noted in male patients (P=0.041) and non-smokers (P=0.013), and was higher in male versus female patients (P=0.031).
  • TNFRSF10C methylation inversely correlated with its mRNA expression (r=-0.379; P=0.008), and demethylation led to significant gene upregulation.

Conclusions:

  • Hypermethylation of the TNFRSF10C gene is significantly associated with non-small cell lung cancer.
  • TNFRSF10C methylation may serve as a potential biomarker for NSCLC, with distinct patterns observed in specific patient subgroups.
  • The findings suggest that TNFRSF10C methylation influences gene expression, potentially impacting NSCLC pathogenesis.